News & Updates

Treatment with pembrolizumab plus belzutifan results in a significant and clinically meaningful improvement in disease-free survival (DFS) compared with pembrolizumab monotherapy in patients with clear cell renal cell carcinoma (ccRCC) who are at greater risk of recurrence following nephrectomy, results from the phase III LITESPARK-022 study have shown.

A study from Argentina shows the potential of an innovative ingestible gastric balloon, an intragastric device that does not require surgery, anaesthesia, or endoscopy, for weight management in individuals with obesity.

COVID-19 vaccination appears to be moderately effective at preventing lingering symptoms following SARS-CoV-2 infection, and this effectiveness may increase with the number of doses administered, according to a meta-analysis.

The timing of cardiac arrest does not appear to influence the return of spontaneous circulation (ROSC) rate or 90-day survival, a Singapore study has shown.